Samsung Pharmaceutical Co Ltd
001360
Company Profile
Business description
Samsung Pharmaceutical Co Ltd is a South Korea-based company engaged in pharmaceutical manufacturing and sales, bio business, and health food sales. The company's products are Prescription drugs, General medicine, Non-medicinal products, Health functional food, and others.
Contact
10, Yakjakgongdan 4-gil
Hyangnam-eup
Gyeonggi-do
Hwaseong-si
KORT: +82 313536681
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
88
Stocks News & Analysis
stocks
Going into earnings, is Alphabet stock a buy, a sell, or fairly valued?
From AI integration to capital expenditure increases, here’s what we expect in Alphabet’s earnings report.
stocks
ASX energy share remains cheap despite strong outlook
Santos reports a solid quarter on the back of higher commodity prices - yet the shares look undervalued.
stocks
Moated AI-proof tech play hiding in the ASX 100
ChatGPT and large language models should be a tailwind for this company.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,006.40 | 19.00 | -0.21% |
| CAC 40 | 8,157.82 | 69.50 | -0.84% |
| DAX 40 | 24,140.87 | 14.58 | -0.06% |
| Dow JONES (US) | 49,270.08 | 40.24 | -0.08% |
| FTSE 100 | 10,379.08 | 77.93 | -0.75% |
| HKSE | 25,978.07 | 62.87 | 0.24% |
| NASDAQ | 24,797.22 | 358.72 | 1.47% |
| Nikkei 225 | 59,716.18 | 575.95 | 0.97% |
| NZX 50 Index | 12,874.94 | 9.99 | -0.08% |
| S&P 500 | 7,162.76 | 54.36 | 0.76% |
| S&P/ASX 200 | 8,786.50 | 12.10 | -0.14% |
| SSE Composite Index | 4,079.90 | 13.35 | -0.33% |